{"title":"Acute Coronary Syndrome Admissions and Mortality Rate During COVID-19 Pandemic in Gaza","authors":"M. Habib","doi":"10.36879/jcr.20.000137","DOIUrl":null,"url":null,"abstract":"Background: What is the nature and duration of changes to admissions for different types of acute coronary syndrome (ACS), among\npatients during coronavirus disease 2019 (COVID-19) pandemic in Gaza?\nMethods: The investigators analyzed data on hospital admissions in Gaza for types of ACS from August 25-2020, to October 1,\n2020, that were recorded in the Alshifa Hospital Cardiology Department Service Admitted Patient Care database. Admissions were\nclassified as ST-elevation myocardial infarction (STEMI) and non-STEACS and we calculate the diagnostic and percutaneous coronary\nintervention (PCI) rate.\nResults: Hospital admissions for ACS declined from rate of 99 admissions to 40 admission in 2020in this time, a reduction of 60%.\nDuring the period of declining admissions, there were reductions in the number of admissions for all types of ACS, including both\nSTEMI and NON-STEACS, but relative and absolute reductions were larger for NSTEMI, (from 73 patients in 2019 to 26 patients in\n2020) with a percent reduction of 64% In parallel, reductions were recorded in the STEMI ( from 26 patients in 2019 to 14 patients\nin 2020) percent reduction 46 %, the mortality rate for STEMI patient was 4% in 2019 and 21% in 2020, for non-STEMI patient was\n0% in 2019 and 4% in 2020.\nThe diagnostic coronary angiography decrease from 130 to 31 cases (76%) and PCI decrease from 35 to 18 cases (49%) during this\nperiod\nConclusions: We found that significant reduction in the number of patients with ACS who were admitted to the hospital during the\npandemic, but increase in mortality rate by 17% in STEMI and 4% in NON-STEACS in Gaza strip","PeriodicalId":15200,"journal":{"name":"Journal of Cardiology & Current Research","volume":"295 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2020-08-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Cardiology & Current Research","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.36879/jcr.20.000137","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Background: What is the nature and duration of changes to admissions for different types of acute coronary syndrome (ACS), among
patients during coronavirus disease 2019 (COVID-19) pandemic in Gaza?
Methods: The investigators analyzed data on hospital admissions in Gaza for types of ACS from August 25-2020, to October 1,
2020, that were recorded in the Alshifa Hospital Cardiology Department Service Admitted Patient Care database. Admissions were
classified as ST-elevation myocardial infarction (STEMI) and non-STEACS and we calculate the diagnostic and percutaneous coronary
intervention (PCI) rate.
Results: Hospital admissions for ACS declined from rate of 99 admissions to 40 admission in 2020in this time, a reduction of 60%.
During the period of declining admissions, there were reductions in the number of admissions for all types of ACS, including both
STEMI and NON-STEACS, but relative and absolute reductions were larger for NSTEMI, (from 73 patients in 2019 to 26 patients in
2020) with a percent reduction of 64% In parallel, reductions were recorded in the STEMI ( from 26 patients in 2019 to 14 patients
in 2020) percent reduction 46 %, the mortality rate for STEMI patient was 4% in 2019 and 21% in 2020, for non-STEMI patient was
0% in 2019 and 4% in 2020.
The diagnostic coronary angiography decrease from 130 to 31 cases (76%) and PCI decrease from 35 to 18 cases (49%) during this
period
Conclusions: We found that significant reduction in the number of patients with ACS who were admitted to the hospital during the
pandemic, but increase in mortality rate by 17% in STEMI and 4% in NON-STEACS in Gaza strip